Related Experiment Videos

[Clinical significance of the terminal complement complex in children with type I membranoproliferative

Yasuaki Kobayashi1, Osamu Hasegawa, Masataka Honda

  • 1Division of Pediatrics, Ohtawara Red Cross Hospital, Tochigi, Japan.

Nihon Jinzo Gakkai Shi
|September 28, 2004
PubMed

Insights

Elevated terminal complement complex (TCC) in pediatric patients with type I membranoproliferative glomerulonephritis (MPGN) indicates poorer treatment response and prognosis. Plasma TCC levels may predict outcomes and guide therapy.

Area of Science:

  • Nephrology
  • Immunology
  • Pediatric Medicine

Context:

  • Type I membranoproliferative glomerulonephritis (MPGN) is a serious kidney disease in children.
  • The role of the complement system, specifically terminal complement complex (TCC), in MPGN pathogenesis is not fully understood.

Purpose:

  • To investigate the correlation between plasma and urinary terminal complement complex (TCC) concentrations and clinical outcomes in pediatric patients with type I MPGN.
  • To assess the diagnostic and prognostic value of TCC levels in this patient population.

Summary:

  • This study measured TCC levels in plasma and urine of pediatric patients with type I MPGN using ELISA and immunoperoxidase staining.
  • Patients with high plasma TCC concentrations showed increased glomerular TCC deposition, higher urinary TCC levels, poorer response to steroid treatment, and worse prognosis.
  • Elevated TCC in circulation appears linked to glomerular TCC formation and urinary excretion, impacting disease course.

Impact:

  • Plasma TCC concentration can serve as a potential biomarker for predicting steroid treatment responsiveness and long-term prognosis in pediatric type I MPGN.
  • Understanding TCC's role may lead to targeted therapeutic strategies for improving outcomes in children with MPGN.

Related Concept Videos

Arboviral Encephalitis01:25

Arboviral Encephalitis

Arboviral encephalitis refers to brain inflammation caused by arthropod-borne viruses, particularly those transmitted through mosquito vectors. Among these, West Nile virus (WNV), a member of the Flaviviridae family, is a significant public health concern. WNV is an enveloped, positive-sense, single-stranded RNA virus. Human infection typically begins when an infected mosquito introduces the virus into the dermis during feeding. The primary transmission cycle involves birds as amplifying hosts...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Encephalitis ll: Pathophysiology01:26

Encephalitis ll: Pathophysiology

Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...